University Medical Center Groningen

Other

Pipeline Programs↗

Distinct drugs in development (Preclinical–Phase 3)

Indications↗

Distinct diseases across all programs

217

Clinical Trials↗

All sponsored trials (all statuses)

Pipeline

Pipeline Snapshot

By Phase

8 drugs in development

Phase 22

Phase 12

Preclinical4

By Therapeutic Area

top 2

Oncology

338%

Cardiovascular

225%

R&D Momentum

73/100

Pipeline Velocity

46/100

Trial Completion Rate

88/100

Pipeline Concentration

34/100

Pipeline Freshness

47/100

Strategic Signals

↗Early-stage heavy pipeline may seek late-stage partners
↗Active in Cardiovascular but thin pipeline — potential licensing opportunity

Activity

Recent Activity

Last 14 days

Nov 4, 2026

Recruiting

The Use of FAPI-PET/CT and FDG-PET/CT Scan in Acute and Chronic Phase Peyronie's Disease for Detection of Active Fibroblasts and Inflammation in the Penis - a Pilot Study

Nov 4, 2026

Recruiting

Establishing a Reference Framework for Outcomes After Machine-Preserved Liver Transplantation in Europe (REFRAME-MP)

Earlier

Oct 21, 2026TrialIndividual and Combined Endothelin Receptor and SGLT2 Antagonism in Adults With Type 1 Diabetes Mellitus and Chronic Kidney Disease: a Phase 2, Multicenter, Open-label Randomized Cross-over Trial

Oct 9, 2026TrialA Randomized Controlled Clinical Trial to Assess the Effect of Dapagliflozin on Renal and Cardiovascular Outcomes in Patients With Severe Chronic Kidney Disease

Oct 9, 2026TrialOff-line Adaptive Proton Therapy

Oct 6, 2026TrialA Phase II Non-inferiority Study Comparing Point-of-care Produced CAR T-cell to Commercial CAR T-cells in Patients With Relapsed/Refractory Non-Hodgkin Lymphoma

Sep 29, 2026TrialEHRA-PATHS: Addressing Multimorbidity in Elderly Atrial Fibrillation Patients Through Interdisciplinary, Patient-centred Systematic Care Pathways - Clinical and Health Economic Evaluation of New Care Pathways

Sep 29, 2026TrialOptimization of Albuminuria Lowering Therapies to Individual Patients With CKD Using FINErenone and SEmaglutide

4 more events

Sep 25, 2026TrialNocturnal Non-Invasive Ventilation in COPD Patients With Stable Hypercapnic Respiratory Failure: Why and in Which Patient Might This be Effective?

Sep 4, 2026TrialUsing the Aflo™ Digital Smart Spacer Platform to Improve Inhaler Technique in Children With Uncontrolled Asthma: A Prospective Pilot Study - INSPIRE-KIDS (INhaler SPacer Improvement & Real-time Education - KIDS)

Sep 1, 2026TrialThyroid Hormone Replacement After Radio Iodine: Value and Efficacy

Aug 26, 2026TrialHYDROchlorothiazide to PROTECT Polycystic Kidney Disease Patients and Improve Their Quality of Life

Details

Company Info

Company Overview

—

Mkt Cap

—

Revenue

—

Cash

Pipeline

Drug Pipeline

Indication

Preclinical

Phase 1

Phase 2

Phase 3

Approved

EuthyroxPreclinical

Oncology

Locally-Advanced Rectal Cancer

ImfinziPhase 1

Ovarian Cancer

DCP-001Phase 1

Solid Tumors

Tiragolumab and atezolizumabPhase 2

Unknown / Other

Fluorescence

with bevacizumab-800CW before bronchoscopyPhase 2

NSCLC

Immunotherapy: adjuvant durvalumabPreclinical

Relapsed/refractory

Axi-celPreclinical

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)